Браузер не даёт сохранять данные (например, приватный режим): закладки пропадут после закрытия вкладки.
Поиск статей PubMed
Ключевые слова, автор, журнал, годы — результаты из PubMed, аннотации с переводом на русский, закладки в браузере.
Найдено: 3 219
Страница 312 из 322-
Multi-Niche Microbiota of a Desert-Adapted Lizard: 16S rRNA Profiling of Teratoscincus roborowskii Endemic to the Turpan Depression in Northwest China.
The microbial communities of desert-dwelling reptiles, such as lizards, are vital for their health and adaptation, yet remain poorly understood. This study provides the first detailed analysis of the microbiome of the Turpan Wonder Gecko (Teratoscincus roborowskii), using 16S rRNA sequencing on samples from its gut, oral cavity and environment in China's Turpan Depression. The results showed distinct microbial profiles across these niches. Key findings include a highly diverse gut microbiota, primarily belonging to the phyla Bacteroidota and Bacillota, as well as thermophilic Thermodesulfobacteriota, which may enhance heat tolerance. The oral microbiota was rich in Pseudomonadota, likely aiding its omnivorous diet. Environmental samples were mostly Cyanobacteriota, typical of desert soils. Gut microbes appear to be specialized in carbohydrate metabolism, while oral microbes may assist in xenobiotic degradation. These results emphasize the important role that the gecko's microbial communities play in its survival in harsh desert conditions.
-
Anorexia nervosa: Gut microbiota-immune-brain interactions.
Anorexia nervosa is a psychiatric disorder defined by an extremely low body weight, a devastating fear of weight gain, and body image disturbance, however the etiopathogenesis remains unclear. The objective of the article is to provide a comprehensive review on the potential role of gut microbiota in pathogenesis of anorexia nervosa. Recent advances in sequencing techniques used for microbial detection revealed that this disease is associated with disruption of the composition of normal gut microbiota (dysbiosis), manifested by low microbial diversity and taxonomic differences as compared to healthy individuals. Microorganisms present in the gut represent a part of the so called "microbiota-gut-brain" axis that affect the central nervous system and thus human behavior via the production of various neuroactive compounds. In addition, cells of the immune system are equipped with receptors for these neuroactive substances. Microbiota of the intestinal system also represent a very important antigenic source. These antigens can mimic some host neuropeptides and neurohormones and thus trigger the production of autoantibodies which cross-react with these compounds. The levels and affinities of these antibodies are thought to be associated with neuropsychiatric conditions including anxiety, depression, and eating and sleep disorders. The study of microbiota function in diseases could bring new insights to the pathogenetic mechanisms.
-
Subconscious Restructuring Protocol in a Mental Health Quality Improvement Study: Reduced Treatment Duration and Improvement Across 17 Psychometric Outcomes in Adult Civilians, Veterans, and Adolescents.
BACKGROUND: Conventional psychiatric and psychotherapeutic services typically require extended treatment durations while collecting limited outcome data, producing inconsistent care. Subconscious Restructuring (SR) uses a behavioral microbiome model treating psychological symptoms and gut barrier integrity as a single clinical target, on the premise that a compromised gut barrier permits translocation of lipopolysaccharide and Candida, activating microglia and the neuroinflammation implicated in depression, anxiety, and post-traumatic stress disorder (PTSD). The model is the rationale for the protocol's dual target, not a hypothesis tested here. SR is cloud-based, scripted, and auditable, capturing session-level client-generated data, and has been in clinical use since 1990; it is mechanistic rather than symptom-based, so no personal history is required for delivery. This quality improvement (QI) initiative aimed to improve the efficiency and clinical outcomes of care by delivering a standardized brief emotional fitness protocol through the SR framework. METHODOLOGY: This initiative used Plan-Do-Study-Act cycles with 50 clients across three populations (20 adult civilians, 20 military veterans, 10 adolescents) in multi-site clinical practices. The protocol comprised two two-hour sessions on consecutive days plus three one-hour follow-ups for adult civilians, two two-hour sessions for veterans, and a single four-hour session for adolescents, delivered as extended workshop-format blocks rather than 50-minute appointments. Sixteen psychometric metrics and a derived Stress Load Index were measured, alongside adherence, completion, and safety. The Gut Health Symptom Checklist was completed at every session as a physician-referral gate, not an outcome measure; no gut health data were analyzed. Change was summarized as the mean change in scale points with SD, 95% CI, percent improvement, and within-subject standardized mean change (d_z); paired t-tests are descriptive. RESULTS: Treatment duration was reduced by 67.5% relative to the 16-hour midpoint of the conventional 12-20-session benchmark, ranging from 56.7% to 74.0% against its 12-hour and 20-hour bounds. Adherence and assessment completion were 100% with no adverse events. Mean improvement across the 17 outcomes was 35.2% for adults, 47.3% for veterans, and 19.1% for adolescents; pooled across 50 clients, depression (Emotional Checklist total) improved 46.63%. Veterans achieved the strongest gains (depression: 57.87%, anger: 63.95%, Stress Load Index: 46.25%). Every outcome improved in raw scale points in all three cohorts, but the adolescent response was smaller and more variable, with 10 of 16 intervals, including zero; its two negative percentages are floor and ceiling artifacts on hopelessness and relationship satisfaction. Standardized Cronbach's alpha was 0.93 for the valence-aligned overall scale, and d_z ranged from 0.04 to 2.04. Reliable improvement on the primary symptom instrument reached 90.0% of veterans, 60.0% of adults, and 50.0% of adolescents; on at least one instrument, these were 95.0%, 95.0%, and 50.0%, respectively. CONCLUSIONS: Standardized brief emotional fitness protocols were associated with improvements in both clinical outcomes and service delivery efficiency. This model offers a replicable framework for reducing treatment timelines; controlled studies are needed to confirm effects on mental health outcomes.
-
Interactions of bile acids and gut microbiota modulate neurological health: a comprehensive review on mechanisms and therapeutic potential of dietary phytochemicals.
Bile acids (BAs), classically regarded as detergents for dietary lipid absorption, have emerged as pivotal signaling molecules with systemic endocrine functions. The discovery of the Farnesoid X Receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5) as BAs-activated receptors unveiled their profound influences on glucose, lipid, and energy metabolism. BAs are first synthesized in hepatocytes and further metabolized by gut microbes, can either circulate in enterohepatic system or be found in circulations to exert various effects. More recently, the gut-brain axis has been identified as a critical pathway through which BAs exert significant effects on central nervous system (CNS) function and health. Based on research progresses mentioned above, this review systematically delineates the synthesis, metabolism, and classification of BAs, with a focus on the intricate crosstalk between the hepatic-gut BA axis and the brain. In addition, we explore the compelling evidences linking BAs dysregulation to a spectrum of neurological disorders, including neurodegenerative diseases (Alzheimer's and Parkinson's disease), depression, and hepatic encephalopathy. Besides, the potential mechanisms, such as alleviating neuroinflammation, maintaining the integrity of blood-brain barrier, increasing the neuronal survival, and modulating neurotransmitter systems are further elucidated. Finally, strategies of dietary intervention through phytochemicals to modulate the BAs pool for improved neurological outcomes are summarized and discussed. By integrating pre-clinical and clinical findings, this review aims to establish a foundation for understanding BAs as novel therapeutic targets in neurology and nutritional neuroscience.
-
Gut microbiota signatures differentiate trajectory-defined response phenotypes and predict self-management outcomes in irritable bowel syndrome.
INTRODUCTION: Heterogeneity in symptom presentation and treatment response in irritable bowel syndrome (IBS) remains poorly understood. This analysis from a randomized controlled trial (NCT03332537) aims to identify symptom-trajectory phenotypes and determine whether gut microbiota composition and function distinguish these phenotypes and predict multidimensional responses to IBS pain self-management interventions. METHODS: Participants with longitudinal data (n = 62) were analyzed using longitudinal k-means clustering based on trajectories of measures in IBS quality of life (QOL), Brief Pain Inventory (BPI), and neuropsychological outcomes (anxiety, applied cognition, depression, fatigue, global health, positive affect, and sleep disturbance) over 12 weeks. Bayesian Additive Regression Trees (BART) models were used to identify baseline microbial taxa and pathways predictive of longitudinal changes in QOL, BPI pain interference, and severity. RESULTS: Two distinct trajectory-defined response phenotypes were identified: a Constrained Response Phenotype (Phenotype A, n = 35) and an Adaptive Multidomain Response Phenotype (Phenotype B, n = 27). At baseline, Phenotype B showed lower pain severity and interference, but higher levels of anxiety, depression, and fatigue compared to Phenotype A. Over 12 weeks, both phenotypes showed improvements in pain outcomes (all p < 0.05), but only Phenotype B demonstrated broad improvements across neuropsychological domains and QOL (all p < 0.05). Phenotype A exhibited more limited improvements and worsening in several neuropsychological domains. Nominal differences in predicted functional pathways were observed, including pathways related to xenobiotic degradation, amino acid metabolism, bile secretion, and immune-related processes (all raw p < 0.05). Although predicted functional pathway differences were not significant after correction for multiple testing, phenotype-specific microbial taxa and functional features were identified as predictors of treatment response in BART models. In Phenotype A, genera such as Alistipes and Sutterella were consistently identified across models, whereas in Phenotype B, predictors included Phascolarctobacterium, Collinsella, and Parabacteroides. CONCLUSIONS: IBS patients exhibit distinct multidimensional response patterns associated with distinct clinical and microbiome profiles. Baseline gut microbial characteristics may serve as potential biomarkers of heterogeneous treatment response in young adults with IBS, supporting a microbiome-based approach to categorize patients and improve personalized self-management strategies in IBS.
-
The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review.
BACKGROUND: Due to the considerable burden of multiple sclerosis (MS)-related symptoms and the need to identify effective interventions to prevent disease progression, various nutraceutical interventions have been trialed as adjunctive treatments. The aim of this review was to investigate the efficacy and safety of nutraceutical interventions for clinical and biological outcomes in people with MS. METHODS: In accordance with PRISMA reporting guidelines, a systematic literature search was conducted using three electronic literature databases. Risk of bias was assessed using the Jadad scale. RESULTS: Thirty-seven randomized controlled trials, investigating fourteen nutraceuticals, were included in the review. Trials that investigated alpha lipoic acid (n = 4/6), ginkgo biloba (n = 3/5), vitamin A (n = 2/2), biotin (n = 1/2), carnitine (n = 1/2), green tea (n = 1/2), coenzyme Q10 (n = 1/1), probiotics (n = 1/1), curcumin (n = 1/1), Andrographis paniculata (n = 1/1), ginseng (n = 1/1), and lemon verbena (n = 1/1) were reported to improve biological (e.g. MRI brain volume change, antioxidant capacity) and/or clinical (e.g. fatigue, depression, Expanded Disability Status Scale) outcomes in multiple sclerosis compared to control. However, most trials were relatively small (average study sample size across included studies, n = 55) and there were few replicate studies per nutraceutical to validate the reported results. Furthermore, some nutraceuticals (e.g. green tea and inosine) should be used with caution due to reported adverse events. Risk of bias across most studies was low, with 31 studies receiving a score between 4 and 5 (out of 5) on the Jadad Scale. CONCLUSION: The existing literature provides preliminary support for the use of a number of nutraceutical interventions in MS. However, sufficiently powered long-term trials are required to expand the currently limited literature and to investigate unexplored nutraceuticals that may target relevant pathways involved in MS such as the gut microbiome and mitochondrial dysfunction. Prospero ID: CRD42018111736.
-
Physiological responses of insects to microbial fermentation products: Insights from the interactions between Drosophila and acetic acid.
Acetic acid is a fermentation product of many microorganisms, including some that inhabit the food and guts of Drosophila. Here, we investigated the effect of dietary acetic acid on oviposition and larval performance of Drosophila. At all concentrations tested (0.34-3.4%), acetic acid promoted egg deposition by mated females in no-choice assays; and females preferred to oviposit on diet with acetic acid relative to acetic acid-free diet. However, acetic acid depressed larval performance, particularly extending the development time of both larvae colonized with the bacterium Acetobacter pomorum and axenic (microbe-free) larvae. The larvae may incur an energetic cost associated with dissipating the high acid load on acetic acid-supplemented diets. This effect was compounded by suppressed population growth of A. pomorum on the 3.4% acetic acid diet, such that the gnotobiotic Drosophila on this diet displayed traits characteristic of axenic Drosophila, specifically reduced developmental rate and elevated lipid content. It is concluded that acetic acid is deleterious to larval Drosophila, and hypothesized that acetic acid may function as a reliable cue for females to oviposit in substrates bearing microbial communities that promote larval nutrition.
-
Pathogenic mechanisms and therapeutic potential of the microbiome in premature ovarian insufficiency.
The postponement of childbearing age has become a global issue. Factors such as increased work pressures on women and environmental changes have led to a rising incidence and younger onset of premature ovarian insufficiency (POI). POI not only impacts patients' reproductive function but also heightens the risk of depression, anxiety, cognitive decline, premature mortality, osteoporosis, and cardiovascular disease. Exploring effective prevention and treatment strategies for POI can slow ovarian ageing and safeguard female reproductive health. Microbiome research confirms that most human tissues and organs form dynamic, interactive systems with symbiotic microbes that play a crucial role in female reproductive function. Previous studies on the microbiome and female reproductive health have rarely focused on POI. The proposed 'Microbiota-Ovary Axis' aims to establish an integrated regulatory framework. This theoretical model systematically elucidates how microbial signals influence ovarian function through four core pathways: the hypothalamic-pituitary-ovarian (HPO) axis, metabolism and endocrine regulation, immunoregulation, and oxidative stress. Evaluating the efficacy of dietary modifications, probiotics, and microbiota transplantation in animal models and preliminary clinical studies will establish a robust theoretical foundation for developing microbiota-targeted innovative diagnostic and therapeutic strategies for POI, thereby enhancing reproductive health throughout the female lifespan.
-
Pretreatment with probiotics Enterococcus faecium NCIMB 11181 attenuated Salmonella Typhimurium-induced gut injury through modulating intestinal microbiome and immune responses with barrier function in broiler chickens.
BACKGROUND: Preventing Salmonella infection and colonization in young birds is key to improving poultry gut health and reducing Salmonella contamination of poultry products and decreasing salmonellosis for human consumption (poultry meat and eggs). Probiotics can improve poultry health. The present study was conducted to investigate the impact of a probiotics, Enterococcus faecium NCIMB 11181 (E. faecium NCIMB 11181) on the intestinal mucosal immune responses, microbiome and barrier function in the presence or absence of Salmonella Typhimurium (S. Typhimurium, ST) infection. METHODS: Two hundred and forty 1-day-old Salmonella-free male broiler chickens (Arbor Acres AA+) were randomly allocated to four groups with 6 replicate cages of 10 birds each. The four experimental groups were follows: (1) negative control (NC), (2) S. Typhimurium, challenged positive control (PC), (3) the E. faecium NCIMB 11181-treated group (EF), (4) the E. faecium NCIMB 11181-treated and S. Typhimurium-challenged group (PEF). RESULTS: Results indicated that, although continuous feeding E. faecium NCIMB 11181 did not obviously alleviate growth depression caused by S. Typhimurium challenge (P > 0.05), E. faecium NCIMB 11181 addition significantly blocked Salmonella intestinal colonization and translocation (P < 0.05). Moreover, supplemental E. faecium NCIMB 11181 to the infected chickens remarkably attenuated gut morphological structure damage and intestinal cell apoptosis induced by S. Typhimurium infection, as evidenced by increasing gut villous height and reducing intestinal TUNEL-positive cell numbers (P < 0.05). Also, E. faecium NCIMB 11181 administration notably promoting the production of anti-Salmonella antibodies in intestinal mucosa and serum of the infected birds (P < 0.05). Additionally, 16S rRNA sequencing analysis revealed that E. faecium NCIMB 11181 supplementation ameliorated S. Typhimurium infection-induced gut microbial dysbiosis by enriching Lachnospiracease and Alistipes levels, and suppressing Barnesiella abundance. Predicted function analysis indicated that the functional genes of cecal microbiome involved in C5-branched dibasic acid metabolism; valine, leucine and isoleucine biosynthesis; glycerolipid metabolism and lysine biosynthesis were enriched in the infected chickens given E. faecium NCIMB 11181. While alanine, asparate and glutamate metabolism; MAPK signal pathway-yeast; ubiquine and other terpenoid-quinore biosynthesis, protein processing in endoplasmic reticulum; as well as glutathione metabolism were suppressed by E. faecium NCIMB 11181 addition. CONCLUSION: Collectively, our data suggested that dietary E. faecium NCIBM 11181 supplementation could ameliorate S. Typhimurium infection-induced gut injury in broiler chickens. Our findings also suggest that E. faecium NCIMB 11181 may serve as an effective non-antibiotic feed additive for improving gut health and controlling Salmonella infection in broiler chickens.
-
Relationship between antibiotic exposure and subsequent mental health disorders in a primary care health system.
OBJECTIVE: To evaluate the relationship between antibiotic exposure and subsequent psychiatric disorders in a Pediatric primary care setting. STUDY DESIGN: We conducted a retrospective cohort study using electronic clinical record data for patients ages 8-20 years seen in the outpatient setting of a large urban primary health care practice from 1/1/13 to 12/1/2018. We employed adjusted Cox regression analyses to study the relationship between prescriptions for anti-infective agents and subsequent diagnosis of anxiety or depression. RESULTS: Prescription of anti-infective medication was associated with a hazard rate ratio (HRR) of 1.21 (95%-CI = 1.00-1.45). A first prescription for a broad-spectrum antibiotic (compared to those with no prescription, narrow-spectrum prescription, or topical prescription) was associated with an HRR of 1.27 (95%-CI = 1.04-1.54). The number of anti-infectives prescribed over the course of the study period was associated with an HRR of 1.05 (95%-CI = 1.00-1.10). There was no significant relationship between prescription of topical or narrow-spectrum antibiotics, antifungal, or antiviral medication and subsequent diagnosis of anxiety or depression. Stratified analysis revealed that the association between anti-infective prescription and anxiety and depression was driven by males, among whom prescription of any antibiotic was associated with an HRR of 1.45 (95%-CI = 1.05-1.99). CONCLUSIONS: Infections treated with broad-spectrum antibiotics were associated with increased risks of anxiety and/or depression, especially in males. Exploration of the relationship between antibiotic exposure and subsequent mental health disorders is warranted along with continued vigilance in antibiotic prescribing practices in children.